Date: Wednesday 18 Aug 2010
Phytopharm, which develops pharmaceutical products derived predominantly from medicinal plants, said its main area of focus will continue to be Cogane, its treatment for Parkinson’s disease.
No recent information was found.
No recent information was found.
No recent information was found.
| UCPI Is Still on the Move: Expects to Begin Dril... | 19-Jul-2006 | Market Wire |
| Currency | US Dollars |
| Share Price | $ 19.40 |
| Change Today | $ 0.15 |
| % Change | 0.78 % |
| 52 Week High | $34.75 |
| 52 Week Low | $19.25 |
| Volume | 15,273,320 |
| Shares Issued | 353.23m |
| Market Cap | $6,853m |
| Beta | 1.42 |
| RiskGrade | 185 |
| Time | Volume / Share Price |
| 16:15 | 95,538 @ $19.40 |
| 16:15 | 340 @ $19.39 |
| 16:15 | 200 @ $19.38 |
| 16:14 | 100 @ $19.39 |
| 16:14 | 103 @ $19.39 |
You are here: research